Postmarketing surveillance. Is not used to promote products
| Autor: | M Vandenburg, W H Inman |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
medicine.medical_specialty
Letter business.industry General Engineering Alternative medicine Postmarketing surveillance General Medicine Audit Public relations Computer security computer.software_genre Advertising Fees and Charges medicine Product Surveillance Postmarketing General Earth and Planetary Sciences Humans business Family Practice computer General Environmental Science Independent research |
| Zdroj: | BMJ (Clinical research ed.). 309(6954) |
| ISSN: | 0959-8138 |
| Popis: | EDITOR, - Simon Voss and Fiona Harris's concerns about postmarketing surveillance need to be challenged.1 Without producing any evidence the authors imply deceit by pharmaceutical companies in three ways: firstly, by using “so called” independent research companies that do not acknowledge their link with the pharmaceutical companies; secondly, by using postmarketing surveillance to promote their products; and, thirdly, by effectively paying general practitioners to prescribe particular drugs. The implication, which the evidence clearly refutes, is that postmarketing surveillance is not carried out to acceptable moral, professional, or scientific standards. We undertake major postmarketing surveillance studies and clearly acknowledge the sponsor when recruiting doctors. These studies are conducted according to all applicable regulations and guidelines, and include review of data; double entry of data; and audit of selected sites, data handling, and statistical procedures. Such rigorous standards, which are not adhered to in most academic research, makes postmarketing surveillance expensive. Postmarketing surveillance is … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|